Wolverine Trading
SAGE

Wolverine Trading’s Sage Therapeutics SAGE Stock Holding History

Wolverine Trading’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-5,000
Closed -$235K – 5011
2023
Q2 		$235K Buy
+5,000
New +$249K ﹤0.01% 3360
2022
Q1 		– Sell
-19,100
Closed -$826K – 6314
2021
Q4 		$826K Sell
19,100
-2,600
-12% -$109K ﹤0.01% 2853
2021
Q3 		$958K Sell
21,700
-11,300
-34% -$518K ﹤0.01% 3047
2021
Q2 		$1.86M Buy
33,000
+12,700
+63% +$898K ﹤0.01% 2063
2021
Q1 		$1.49M Buy
20,300
+5,500
+37% +$451K ﹤0.01% 2265
2020
Q4 		$1.31M Buy
14,800
+800
+6% +$59K ﹤0.01% 2105
2020
Q3 		$835K Buy
14,000
+2,300
+20% +$117K ﹤0.01% 2246
2020
Q2 		$489K Sell
11,700
-20,900
-64% -$759K ﹤0.01% 2754
2020
Q1 		$962K Buy
+32,600
New +$1.89M ﹤0.01% 1964
2019
Q1 		– Sell
-23,200
Closed -$2.06M – 5201
2018
Q4 		$2.06M Buy
23,200
+1,000
+5% +$114K 0.01% 1383
2018
Q3 		$3.14M Buy
+22,200
New +$3.43M 0.01% 1298
2018
Q1 		– Sell
-82,100
Closed -$13.5M – 5738
2017
Q4 		$13.5M Buy
82,100
+53,600
+188% +$5.2M 0.05% 371
2017
Q3 		$1.78M Sell
28,500
-7,200
-20% -$565K 0.01% 1423
2017
Q2 		$2.82M Buy
+35,700
New +$2.58M 0.01% 1011
2017
Q1 		– Sell
-26,100
Closed -$1.33M – 4900
2016
Q4 		$1.33M Sell
26,100
-3,400
-12% -$160K 0.01% 1659
2016
Q3 		$1.34M Buy
+29,500
New +$1.2M 0.01% 1606

Other funds holding SAGE

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wolverine Trading's SAGE Position: Q3 2025 in Review

Wolverine Trading sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 18,390 shares — an estimated $168K sold.

Wolverine Trading first reported a position in SAGE in Q3 2016 and held it in 16 quarters. The position peaked at $1.61M in Q4 2017. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

  • Wolverine Trading reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Wolverine Trading sold 18,390 Sage Therapeutics shares in Q3 2025, an estimated $168K.
  • Wolverine Trading first reported a position in Sage Therapeutics in Q3 2016 and held it in 16 quarters.
  • Wolverine Trading's Sage Therapeutics position peaked at $1.61M in Q4 2017.
  • 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.